p53 mutations have no additional prognostic value over stage in bladder cancer.

doi:10.1038/bjc.1994.334

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

p53 mutations have no additional prognostic value over stage in bladder cancer.

British journal of cancer - 1 Sept 1994

Vet J A, Bringuier P P, Poddighe P J, Karthaus H F, Debruyne F M, Schalken J A

Abstract excerpt

Evidence is accumulating that the tumour-suppressor gene p53 is involved in the development of bladder cancer. Therefore we studied p53 mutations in 47 bladder cancers obtained from 45 patients using polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis. Eight out...

Topics

Adult
Aged
Aged, 80 and over
Alleles
Base Sequence
Carcinoma, Squamous Cell
Carcinoma, Transitional Cell
DNA, Single-Stranded
Gene Deletion
Genes, p53
Humans
Middle Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Molecular Sequence Data

Mutation

Neoplasm Staging

Nucleic Acid Conformation

Polymerase Chain Reaction

Polymorphism, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 8080737
DOI: 10.1038/bjc.1994.334
PMCID: PMC2033347

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8080737-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutations have no additional prognostic value over stage in bladder cancer.PMID 8080737Read ↗

Prognostic implications of p53 gene mutations in bladder tumors.Semantic proximity Read ↗

Frequent association of p53 gene mutation in invasive bladder cancer.Semantic proximity Read ↗

p53 mutations in human bladder cancer.Semantic proximity Read ↗

P53 mutations in urinary bladder cancer patients from Central Poland.Semantic proximity Read ↗

Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects.Semantic proximity Read ↗

Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.Semantic proximity Read ↗

TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.Semantic proximity Read ↗

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.Semantic proximity Read ↗

Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.Semantic proximity Read ↗

Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study.Semantic proximity Read ↗

Analyses of p53 gene mutations in primary human bladder cancer.Semantic proximity Read ↗

P53 codon 72 polymorphism in bladder cancer--no evidence of association with increased risk or invasiveness.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.